Discontinuation report NOVAHISTINE DH
Report ID | 98377 |
Drug Identification Number | 02049473 |
Brand name | NOVAHISTINE DH |
Common or Proper name | Novahistine DH |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE |
Strength(s) | 10MG 1.7MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 100ml |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-06-30 |
Actual discontinuation date | 2020-07-10 |
Remaining supply date | 2020-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | last lot 8115892 expiry 2021-10-17 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-11 | English | Compare |
v2 | 2019-11-11 | French | Compare |
v3 | 2020-08-03 | English | Compare |
v4 | 2020-08-03 | French | Compare |
v5 | 2020-08-04 | English | Compare |
v6 | 2020-08-04 | French | Compare |
Showing 1 to 6 of 6